Supercritical CO₂ Processing Generates Aqueous Cisplatin Solutions with Enhanced Cancer Specificity

Area of Science:

• Materials Science
• Nanotechnology
• Pharmaceutical Science

Background:

• Cisplatin is a vital chemotherapeutic agent, but its clinical utility is limited by high toxicity and poor water solubility.
• Developing improved cisplatin formulations is crucial for enhancing cancer treatment efficacy and patient outcomes.

Purpose of the Study:

• To engineer a more water-soluble and better-tolerated cisplatin formulation using supercritical fluid technology.
• To characterize the physicochemical properties and evaluate the in vitro and in vivo efficacy of the novel cisplatin formulation.

Main Methods:

• Utilized the Rapid Expansion of Supercritical Solutions (RESS) technique with supercritical carbon dioxide (sc-CO2) to create cisplatin nanoclusters.
• Characterized the RESS-processed cisplatin using various material analysis techniques.
• Assessed in vitro cytotoxicity and in vivo toxicity in zebrafish embryos.

Main Results:

• RESS technique yielded stable, highly soluble cisplatin solutions (up to 15x greater solubility).
• In vitro studies showed increased cell viability and early apoptosis with RESS-cisplatin compared to standard cisplatin.
• In vivo studies demonstrated reduced general cell death and improved tolerability of RESS-cisplatin in zebrafish embryos.

Conclusions:

• The RESS technique successfully produced a more water-soluble and less toxic cisplatin formulation.
• RESS-processed cisplatin exhibits promising potential for novel drug delivery routes in pharmaceutical development.
• This advancement could lead to improved cancer therapies with reduced side effects.